儿童单倍体造血干细胞移植后发生慢性移植物抗宿主病的免疫动力学特征与预测因素分析OA
Immune dynamics and predictive factors for chronic graft versus host disease following haploidentical hematopoietic stem cell transplantation in children
目的 探讨单倍体异基因造血干细胞移植术后患儿慢性移植物抗宿主病(chronic graft versus host disease,cGVHD)的免疫学特征及预测因子,为早期干预提供依据.方法 回顾性分析64例单倍体造血干细胞移植患儿的临床及实验室数据,检测外周血淋巴细胞亚群、免疫球蛋白及补体系统关键成分,通过单因素及多因素logistic回归分析筛选预测因子.结果 cGVHD组(n=37)的辅助/诱导T淋巴细胞百分比、补体C3水平显著高于非cGVHD组(n=27),B细胞和自然杀伤细胞百分比显著低于非cGVHD组,差异均有统计学意义(P<0.05).多因素logistic回归分析显示,辅助/诱导T淋巴细胞百分比(OR=1.144,P=0.012)与补体C3水平(OR=29.758,P=0.037)是cGVHD发生的独立预测因素.结论 cGVHD的发生与T细胞稳态失衡、B细胞功能耗竭及补体系统异常激活密切相关.辅助性T淋巴细胞百分比和补体C3水平可作为cGVHD发生的潜在预测指标.
Objective To investigate the immunological characteristics and predictive factors of chronic graft-versus-host disease(cGVHD)in children after haploidentical allogeneic hematopoietic stem cell transplantation(Haplo-HSCT)to provide a basis for early intervention.Methods A retrospective analysis was conducted on clinical and laboratory data of 64 children undergoing Haplo-HSCT.Peripheral blood lymphocyte subsets,immunoglobulins,and key components of the complement system were measured.Univariable and multivariable logistic regression analyses were used to identify predictors.Results The percentage of helper/inducer T lymphocytes and complement C3 levels were significantly higher in the cGVHD group(n=37)compared to the non-cGVHD group(n=27)(P<0.05),while the percentages of B cells and natural killer(NK)cells were significantly lower(P<0.05).Multivariate logistic regression identified the percentage of helper/inducer T lymphocytes(OR=1.144,P=0.012)and complement C3 level(OR=29.758,P=0.037)as independent predictors of cGVHD.Conclusions The development of cGVHD is closely associated with T-cell homeostasis imbalance,B-cell functional exhaustion,and abnormal activation of the complement system.The percentage of helper/inducer T lymphocytes and complement C3 levels may serve as potential predictive indicators for cGVHD occurrence.
唐冉冉;刘四喜;付笑迎;赵宇阳;李越;周小辉;陈诗杨;段秋悦;彭冬;邝雅贤;罗丽萍
深圳市儿童医院检验科,广东 深圳 518038||重庆医科大学检验医学院,重庆 400016深圳市儿童医院血液肿瘤科,广东 深圳 518038深圳市儿童医院检验科,广东 深圳 518038深圳市儿童医院检验科,广东 深圳 518038深圳市儿童医院血液肿瘤科,广东 深圳 518038深圳市儿童医院血液肿瘤科,广东 深圳 518038深圳市儿童医院检验科,广东 深圳 518038深圳市儿童医院检验科,广东 深圳 518038深圳市儿童医院检验科,广东 深圳 518038深圳市儿童医院检验科,广东 深圳 518038深圳市儿童医院检验科,广东 深圳 518038
慢性移植物抗宿主病单倍体造血干细胞移植淋巴细胞亚群体液免疫免疫重建儿童
Chronic graft-versus-host diseaseHaploidentical hematopoietic stem cell transplantationLymphocyte subsetHumoral immunityImmune reconstitutionChild
《中国当代儿科杂志》 2026 (6)
736-743,8
深圳市科技创新委员会基础研究面上项目(JCYJ20210324142201004).
评论